* the patient is enrolled in another clinical trial that involves antibacterial therapy. * the patient's goals of care is anticipated to be designated "total compassionate care" or palliative care within 48 hours of admission. * the patient's progression to death is anticipated to be imminent and inevitable within 48 hours of admission. * the patient was attended by any member of the research team within 30 days of enrollment. * the patient is transferred from another acute care center.

* the patient is enrolled in another clinical trial that involves antibacterial therapy. * the patient's goals of care is anticipated to be designated "total compassionate care" or palliative care within 48 hours of admission. * the patient's progression to death is anticipated to be imminent and inevitable within 48 hours of admission. * the patient was attended by any member of the research team within 30 days of enrollment. * the patient is transferred from another acute care center.

- the patient is enrolled in another clinical trial that involves antibacterial therapy. - the patient's goals of care is anticipated to be designated "total compassionate care" or palliative care within 48 hours of admission. - the patient's progression to death is anticipated to be imminent and inevitable within 48 hours of admission. - the patient was attended by any member of the research team within 30 days of enrollment. - the patient is transferred from another acute care center.

- the patient is enrolled in another clinical trial that involves antibacterial therapy. - the patient's goals of care is anticipated to be designated "total compassionate care" or palliative care within 48 hours of admission. - the patient's progression to death is anticipated to be imminent and inevitable within 48 hours of admission. - the patient was attended by any member of the research team within 30 days of enrollment. - the patient is transferred from another acute care center.

- the patient is enrolled in another clinical trial that involves antibacterial therapy. - the patient's goals of care is anticipated to be designated "total compassionate care" or palliative care within 48 hours of admission. - the patient's progression to death is anticipated to be imminent and inevitable within 48 hours of admission. - the patient was attended by any member of the research team within 30 days of enrollment.

- the patient is enrolled in another clinical trial that involves antibacterial therapy. - the patient's goals of care is anticipated to be designated "total compassionate care" or palliative care within 48 hours of admission. - the patient's progression to death is anticipated to be imminent and inevitable within 48 hours of admission. - the patient was attended by any member of the research team within 30 days of enrollment.